About
About Towa Pharmaceutical Co., Ltd
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. The company operates through two segments; Domestic and Overseas. It provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from tablets, capsules, injectable, patches, eye drops, and other products. The company also offers IT service related to healthcare; disease risk testing services; and sale of quasi drugs. In addition, it is involved in research and development and production of active pharmaceutical ingredients, intermediates, and support business; and planning, development and OEM manufacturing of health foods, pharmaceuticals, general foods, and other miscellaneous merchandizes. Towa Pharmaceutical Co., Ltd. was founded in 1951 and is headquartered in Kadoma, Japan.
Visit company website
5 years, 6 months ago
Towa Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 14.9% above its 200 day moving average.
From a valuation standpoint, the stock is 98.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.8.
Towa Pharmaceutical Co., Ltd's total revenue rose by 39.8% to $41B since the same quarter in the previous year.
Its net income has dropped by 18.1% to $3B since the same quarter in the previous year.
Based on the above factors, Towa Pharmaceutical Co., Ltd gets an overall score of 3/5.